The latest cancer news from the U.S. government's principal agency for cancer research.
  1. Engineered immune cells deliver anticancer signal, prevent cancer from spreading

    In an NCI study, treating mice with engineered immune cells shrank tumors and prevented the cancer from spreading to other parts of the body. The immunotherapy approach shows promise as a potential treatment for metastatic cancer.
  2. NCI statement on ending structural racism in biomedical research

    Statement from the National Cancer Institute in support of the NIH UNITE initiative to end structural racism in biomedical research. NCI Director Dr. Norman Sharpless describes NCI’s equity and inclusion efforts.
  3. NCI study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection

    A prior infection with SARS-CoV-2, the virus that causes COVID-19, appears to protect, at least for a few months, against reinfection from the virus, according to an NCI study. The finding may have important public health implications.
  4. Fecal microbiota transplants help patients with advanced melanoma respond to immunotherapy

    For patients with cancers that do not respond to immunotherapy drugs, the use of fecal transplants to modify the gut microbiome may help some of these patients respond to the immunotherapy drugs.
  5. Some postmenopausal women with breast cancer may forgo chemotherapy

    Some postmenopausal women with HR-positive, HER2-negative breast cancer may not benefit from chemotherapy and can safely forgo the treatment, according to clinical trial results presented at the San Antonio Breast Cancer Symposium.
  6. Study of “exceptional responders” yields clues to cancer and potential treatments

    A comprehensive analysis of patients with cancer who had exceptional responses to therapy has revealed molecular changes in the patients’ tumors that may explain some of the exceptional responses.
  7. NCI, NIBIB award contracts to develop innovative digital health technologies for COVID-19

    NCI and the National Institute of Biomedical Imaging and Bioengineering have awarded seven contracts to develop digital health solutions, like smartphone apps, wearable devices, and software, that help address the COVID-19 pandemic.
  8. NCI, Cancer Research UK launch Cancer Grand Challenges partnership to support bold new ideas for cancer research

    NCI and Cancer Research UK will partner to fund Cancer Grand Challenges, an international initiative to address profound and unanswered questions in cancer research.
  9. New treatments spur sharp reduction in lung cancer mortality rate

    Mortality rates from the most common lung cancer, non-small cell lung cancer (NSCLC), have fallen sharply in the United States in recent years, due primarily to recent advances in treatment, an NCI study shows.
  10. AI dual-stain approach improved accuracy, efficiency of cervical cancer screening in NCI study

    In a new study, an automated dual-stain method using artificial intelligence improved the accuracy and efficiency of cervical cancer screening compared with the current standard for follow-up of women who test positive with primary HPV screening.